Public-domain · open source
OpenJurist
← 521 U.S. 642 - United States v. O'Hagan

United States v. O'Hagan’s Empirical Analysis

1997

Citation profile

953
cited by 953 later decisions
25
cited 25 times by the Supreme Court
7
states following
September 2024
most recently cited

298 federal appellate · 90 district · 22 state decisions

How this case has been cited

Cited by 953 later decisions (25 by the Supreme Court) — most recently September 2024 · most notably United States v. Mead Corp. (2001), Dura Pharmaceuticals, Inc. v. Broudo (2005)

298 federal appellate · 90 district · 22 state decisions

46901997200020102020decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Appellate journey

reviewedUnited States v. O'Hagan (from Eighth Circuit Court of Appeals)

Relationships

Relies on Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc. · Motor Vehicle Manufacturers Association of United States Inc v. State Farm Mutual Automobile Insurance Company Consumer Alert · Ernst & Ernst v. Hochfelder · Securities and Exchange Commission v. Chenery Corporation Same · Securities and Exchange Commission v. Chenery Corporation

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 953 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “[T]he misappropriation theory premises liability on a fiduciary-turned-trader's deception of those who entrusted him with access to confidential information.”
    43 later decisions quote this exact passage · from the dissent
  2. “It shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality of interstate commerce, or of the mails or of any facility of any national securities exchange, (a) To employ any device, scheme, or artifice to defraud, (b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or (c) To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person, in connection with the purchase or sale of any security.”
    21 later decisions quote this exact passage · from the dissent
  3. “are violated when a corporate insider trades in the securities of his corporation on the basis of material, nonpublic information.”
    16 later decisions quote this exact passage · from the dissent

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.